시장보고서
상품코드
1150081

세계의 오소바이오로직스 시장 점유율, 규모, 동향, 업계 분석 : 최종 용도별, 제품별, 용도별, 지역별, 부문 예측(2022-2030년)

Orthobiologics Market Share, Size, Trends, Industry Analysis Report, By End-Use (Hospitals, Orthopedic Clinics, Ambulatory Care Centers, Research & Academic Institutes, Others); By Product; By Application; By Region; Segment Forecast, 2022 - 2030

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 오소바이오로직스 시장 규모는 2030년까지 117억 7,000만 달러에 달할 것으로 예측되고 있습니다.

세계의 오소바이오로직스 시장을 조사했으며, 시장의 개요, 시장 규모 및 예측, 동향, 촉진요인·억제요인, 최종 용도별·제품별·용도별·지역별 등의 분석 및 기업 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

  • 리포트 설명
    • 조사의 목적
    • 시장 범위
    • 전제조건
  • 이해관계자

제2장 주요 요약

  • 시장 하이라이트

제3장 조사 방법

  • 개요
    • 데이터 마이닝
  • 정보원
    • 1차 정보
    • 2차 정보

제4장 세계의 오소바이오로직스 시장 인사이트

  • 오소바이오로직스 - 업계의 스냅숏
  • 오소바이오로직스 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter's Five Forces 분석
    • 공급 기업의 교섭력
    • 신규 참여업체의 위협
    • 구매자의 교섭력
    • 대체품의 위협
    • 기존 기업간 경쟁 관계
  • PESTEL 분석
  • 오소바이오로직스 시장 업계 동향
  • 밸류체인 분석
  • COVID-19 영향 분석

제5장 세계의 오소바이오로직스 시장 : 제품별

  • 주요 조사 결과
  • 서론
    • 세계의 오소바이오로직스 시장, 제품별(2018-2030년)
  • 탈회골기질(DBM)
    • 세계의 오소바이오로직스 시장, 탈회골기질(DBM)별, 지역별(2018-2030년)
  • 동종이식편
    • 세계의 오소바이오로직스 시장, 동종이식편별, 지역별(2018-2030년)
  • 골형성 단백질(BMP)
    • 세계의 오소바이오로직스 시장, 골형성 단백질(BMP)별, 지역별(2018-2030년)
  • 관절내 점성보충
    • 세계의 오소바이오로직스 시장, 관절내 점성보충별, 지역별(2018-2030년)
  • 인공골 대용품
    • 세계의 오소바이오로직스 시장, 인공골 대용품별, 지역별(2018-2030년)
  • 줄기세포 요법
    • 세계의 오소바이오로직스 시장, 줄기세포 요법별, 지역별(2018-2030년)
  • 기타
    • 세계의 오소바이오로직스 시장, 기타별, 지역별(2018-2030년)

제6장 세계의 오소바이오로직스 시장 : 용도별

  • 주요 조사 결과
  • 서론
    • 세계의 오소바이오로직스 시장, 용도별(2018-2030년)
  • 척추고정술
    • 세계의 오소바이오로직스 시장, 척추고정술별, 지역별(2018-2030년)
  • 외상 수복
    • 세계의 오소바이오로직스 시장, 외상 수복별, 지역별(2018-2030년)
  • 골관절염·변성 관절염
    • 세계의 오소바이오로직스 시장, 골관절염·변성 관절염별, 지역별(2018-2030년)
  • 연조직 손상
    • 세계의 오소바이오로직스 시장, 연조직 손상별, 지역별(2018-2030년)
  • 악안면·치과 용도
    • 세계의 오소바이오로직스 시장, 악안면·치과 용도별, 지역별(2018-2030년)
  • 재건 수술
    • 세계의 오소바이오로직스 시장, 재건 수술별, 지역별(2018-2030년)

제7장 세계의 오소바이오로직스 시장 : 최종 용도별

  • 주요 조사 결과
  • 서론
    • 세계의 오소바이오로직스 시장 : 최종 용도별
  • 병원
    • 세계의 오소바이오로직스 시장, 병원별, 지역별(2018-2030년)
  • 정형외과 클리닉
    • 세계의 오소바이오로직스 시장, 정형외과 클리닉별, 지역별(2018-2030년)
  • 외래 진료 센터
    • 세계의 오소바이오로직스 시장, 외래 진료 센터별, 지역별(2018-2030년)
  • 연구·학술기관
    • 세계의 오소바이오로직스 시장, 연구·학술기관별, 지역별(2018-2030년)
  • 기타
    • 세계의 오소바이오로직스 시장, 기타별, 지역별(2018-2030년)

제8장 세계의 오소바이오로직스 시장 : 지역별

  • 주요 조사 결과
  • 서론
    • 오소바이오로직스 시장 평가, 지역별(2018-2030년)
  • 오소바이오로직스 시장 - 북미
    • 북미 : 오소바이오로직스 시장, 제품별(2018-2030년)
    • 북미 : 오소바이오로직스 시장, 최종 용도별(2018-2030년)
    • 북미 : 오소바이오로직스 시장, 용도별(2018-2030년)
    • 오소바이오로직스 시장 - 미국
    • 오소바이오로직스 시장 - 캐나다
  • 오소바이오로직스 시장 - 유럽
    • 유럽 : 오소바이오로직스 시장, 제품별(2018-2030년)
    • 유럽 : 오소바이오로직스 시장, 최종 용도별(2018-2030년)
    • 유럽 : 오소바이오로직스 시장, 용도별(2018-2030년)
    • 오소바이오로직스 시장 - 영국
    • 오소바이오로직스 시장 - 프랑스
    • 오소바이오로직스 시장 - 독일
    • 오소바이오로직스 시장 - 이탈리아
    • 오소바이오로직스 시장 - 스페인
    • 오소바이오로직스 시장 - 네덜란드
    • 오소바이오로직스 시장 - 러시아
  • 오소바이오로직스 시장 - 아시아태평양
    • 아시아태평양 : 오소바이오로직스 시장, 제품별(2018-2030년)
    • 아시아태평양 : 오소바이오로직스 시장, 최종 용도별(2018-2030년)
    • 아시아태평양 : 오소바이오로직스 시장, 용도별(2018-2030년)
    • 오소바이오로직스 시장 - 중국
    • 오소바이오로직스 시장 - 인도
    • 오소바이오로직스 시장 - 말레이시아
    • 오소바이오로직스 시장 - 일본
    • 오소바이오로직스 시장 - 인도네시아
    • 오소바이오로직스 시장 - 한국
  • 오소바이오로직스 시장 - 중동·아프리카
    • 중동·아프리카 : 오소바이오로직스 시장, 제품별(2018-2030년)
    • 중동·아프리카 : 오소바이오로직스 시장, 최종 용도별(2018-2030년)
    • 중동·아프리카 : 오소바이오로직스 시장, 용도별(2018-2030년)
    • 오소바이오로직스 시장 - 사우디아라비아
    • 오소바이오로직스 시장 - 아랍에미리트
    • 오소바이오로직스 시장 - 이스라엘
    • 오소바이오로직스 시장 - 남아프리카공화국
  • 오소바이오로직스 시장 - 라틴아메리카
    • 라틴아메리카 : 오소바이오로직스 시장, 제품별(2018-2030년)
    • 라틴아메리카 : 오소바이오로직스 시장, 최종 용도별(2018-2030년)
    • 라틴아메리카 : 오소바이오로직스 시장, 용도별(2018-2030년)
    • 오소바이오로직스 시장 - 멕시코
    • 오소바이오로직스 시장 - 브라질
    • 오소바이오로직스 시장 - 아르헨티나

제9장 경쟁 구도

  • 확대·인수 분석
    • 확대
    • 인수
  • 파트너십/협업/협정/공개

제10장 기업 개요

  • Alphatec Spine Incorporation
  • Arthrex Inc.
  • Bone Biologics Corporation
  • Bacterin International Corporation
  • DePuy Synthes, Incorporation
  • Exactech, Inc
  • Genzyme Corporation
  • Globus Medical, Inc
  • Globus Medical, Inc
  • Harvest Technologies Corporation
  • Integra Lifesciences Corporation
  • Medtronic, Plc
  • NuVasive, Incorporation
  • Orthofix Holdings, Inc
  • Ortho Regenerative Technologies Inc
  • Stryker Corporation
  • SeaSpine Holdings Corporation
  • Wright Medical Group N.V
  • Zimmer Biomet, Inc
KSA 22.12.05

The global orthobiologics market size is expected to reach USD 11.77 billion by 2030, according to a new study by Polaris Market Research. The report "Orthobiologics Market Share, Size, Trends, Industry Analysis Report, By Product (Demineralized Bone Matrix(DBM), Allograft, Bone Morphogenetic Protein (BMP), Viscosupplementation, Synthetic Bone Substitutes, Stem Cell Therapy, and Others); By Application; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increased use of platelet-rich plasma, homologous conditioned plasma, and adipose-generated stromal cell treatment is also predicted to contribute to market expansion. Orthobiologics, which are most usually connected with sports injuries, are organic substances, including platelet-rich plasma (PRP) or stem cells, that are used to accelerate the recovery process for musculoskeletal problems.

They can be used alone as well as in conjunction with traditional pharmacological and non-pharmaceutical therapy options. Orthobiologic therapies, in particular, consider introducing large concentrations of natural sources of cellular ingredients to an injury site to accelerate the recovery process of muscles, ligaments, soft tissue, joints, and other organs, thereby reducing recovery time and due to injuries pain, and swelling.

Further, the development in the occurrence of sports injuries and road accidents is likely to drive the growth of the market during the forecast period. As per the John Hopkins Medicines, in the United States, about 30 million children and teenagers participate in some type of sports, and every year, around 3.5 million injuries occur, which results in some loss of engagement time.

Thus, orthobiologic therapies are utilized in sports medicine to treat either acute or chronic disorders, including typical overuse injuries. Athletes and orthopedists frequently turn to orthobiologic therapy to quickly recover an athlete to the pre-injury physical state. Most orthopedists will try to employ biologics instead of medications and/or intrusive surgery.

Furthermore, the rise in the prevalence of spinal illnesses and disorders is expected to fuel the expansion of the market. For instance, as per the National Spinal Cord Injury Statistical Center, the average annual incidence of SCI is around 54 instances per one million individuals, or approximately 17,810 additional SCI cases each year.

As per the WHO, every year, approximately 250 000 and 500 000 people worldwide develop a spinal cord injury (SCI). Most spinal cord accidents are caused by avoidable causes such as car accidents and falls. Therefore, the rising prevalence of sports injuries along with spinal disorders are the factors that are boosting the demand for orthobiologics therapy or treatment and are driving the market growth.

Orthobiologics Market Report Highlights

The soft tissue injuries segment is anticipated to grow at the fastest CAGR over the forecast period owing to a rise in sports-related injuries and the desire for orthobiologics for cartilage regeneration.

Spinal fusion segment accounted for a significant share of the global revenue due to the rising use of artificial matrices and allografts in spine fusion surgeries.

Asia Pacific is expected to witness substantial growth over the projected period. This is growing owing to increased healthcare spending, rising disposable personal wealth, and an increase in road traffic accidents in various nations. The public funding for health education and services is also rising.

The global players include Alphatec Spine Incorporation, DePuy Synthes, Incorporation, Exactech, Inc., Globus Medical, Inc., Globus Medical, Inc., Harvest Technologies Corporation, Orthofix Holdings, Inc., Stryker Corporation, SeaSpine Holdings Corporation, Wright Medical Group N.V., and Zimmer Biomet, Inc.

Polaris Market Research has segmented the Orthobiologics market report based on product, application, end-use, and region:

Orthobiologics, Product Outlook (Revenue - USD Billion, 2018 - 2030)

Demineralized Bone Matrix(DBM)

Allograft

Bone Morphogenetic Protein (BMP)

Viscosupplementation

Synthetic Bone Substitutes

Stem Cell Therapy

Others

Orthobiologics, Application Outlook (Revenue - USD Billion, 2018 - 2030)

Spinal Fusion

Trauma Repair

Osteoarthritis and Degenerative Arthritis

Soft Tissue Injuries

Maxillofacial and Dental Applications

Reconstructive Surgery

Orthobiologics, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals

Orthopedic Clinics

Ambulatory Care Centers

Research and Academic Institutes

Others

Orthobiologics, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Orthobiologics Market Insights

  • 4.1. Orthobiologics - Industry Snapshot
  • 4.2. Orthobiologics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growth in aging population
      • 4.2.1.2. Increase in sports injuries
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of orthobiologics product
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Orthobiologics Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Orthobiologics Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
  • 5.3. Demineralized Bone Matrix(DBM)
    • 5.3.1. Global Orthobiologics Market, by Demineralized Bone Matrix(DBM), by Region, 2018 - 2030 (USD Billion)
  • 5.4. Allograft
    • 5.4.1. Global Orthobiologics Market, by Allograft, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Bone Morphogenetic Protein (BMP)
    • 5.5.1. Global Orthobiologics Market, by Bone Morphogenetic Protein (BMP), by Region, 2018 - 2030 (USD Billion)
  • 5.6. Viscosupplementation
    • 5.6.1. Global Orthobiologics Market, by Viscosupplementation, by Region, 2018 - 2030 (USD Billion)
  • 5.7. Synthetic Bone Substitutes
    • 5.7.1. Global Orthobiologics Market, by Synthetic Bone Substitutes, by Region, 2018 - 2030 (USD Billion)
  • 5.8. Stem Cell Therapy
    • 5.8.1. Global Orthobiologics Market, by Stem Cell Therapy, by Region, 2018 - 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Global Other Orthobiologics Market, by Region, 2018 - 2030 (USD Billion)

6. Global Orthobiologics Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 6.3. Spinal Fusion
    • 6.3.1. Global Orthobiologics Market, by Spinal Fusion, by Region, 2018 - 2030 (USD Billion)
  • 6.4. Trauma Repair
    • 6.4.1. Global Orthobiologics Market, by Trauma Repair, by Region, 2018 - 2030 (USD Billion)
  • 6.5. Osteoarthritis and Degenerative Arthritis
    • 6.5.1. Global Orthobiologics Market, by Osteoarthritis and Degenerative Arthritis, by Region, 2018 - 2030 (USD Billion)
  • 6.6. Soft Tissue Injuries
    • 6.6.1. Global Orthobiologics Market, by Soft Tissue Injuries, by Region, 2018 - 2030 (USD Billion)
  • 6.7. Maxillofacial and Dental Applications
    • 6.7.1. Global Orthobiologics Market, by Maxillofacial and Dental Applications, by Region, 2018 - 2030 (USD Billion)
  • 6.8. Reconstructive Surgery
    • 6.8.1. Global Orthobiologics Market, by Reconstructive Surgery, by Region, 2018 - 2030 (USD Billion)

7. Global Orthobiologics Market, by End-Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Orthobiologics Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Orthopedic Clinics
    • 7.4.1. Global Orthobiologics Market, by Orthopedic Clinics, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Ambulatory Care Centers
    • 7.5.1. Global Orthobiologics Market, by Ambulatory Care Centers, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Research and Academic Institutes
    • 7.6.1. Global Orthobiologics Market, by Research and Academic Institutes, by Region, 2018 - 2030 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Other Orthobiologics Market, by Region, 2018 - 2030 (USD Billion)

8. Global Orthobiologics Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Orthobiologics Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 8.3. Orthobiologics Market - North America
    • 8.3.1. North America: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.3.2. North America: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.3.3. North America: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.3.4. Orthobiologics Market - U.S.
      • 8.3.4.1. U.S.: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.3.4.2. U.S.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.3.4.3. U.S.: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.3.5. Orthobiologics Market - Canada
      • 8.3.5.1. Canada: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.3.5.2. Canada.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.3.5.3. Canada: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.4. Orthobiologics Market - Europe
    • 8.4.1. Europe: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.4.2. Europe.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.3. Europe: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.4. Orthobiologics Market - UK
      • 8.4.4.1. UK: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.4.2. UK.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.4.3. UK: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.5. Orthobiologics Market - France
      • 8.4.5.1. France: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.5.2. France.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.5.3. France: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.6. Orthobiologics Market - Germany
      • 8.4.6.1. Germany: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.6.2. Germany.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.6.3. Germany: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.7. Orthobiologics Market - Italy
      • 8.4.7.1. Italy: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.7.2. Italy.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.7.3. Italy: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.8. Orthobiologics Market - Spain
      • 8.4.8.1. Spain: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.8.2. Spain.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.8.3. Spain: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.9. Orthobiologics Market - Netherlands
      • 8.4.9.1. Netherlands: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.9.2. Netherlands.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.9.3. Netherlands: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.4.10. Orthobiologics Market - Russia
      • 8.4.10.1. Russia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.4.10.2. Russia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.4.10.3. Russia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.5. Orthobiologics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.5.2. Asia Pacific.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.3. Asia Pacific: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.4. Orthobiologics Market - China
      • 8.5.4.1. China: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.4.2. China.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.4.3. China: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.5. Orthobiologics Market - India
      • 8.5.5.1. India: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.5.2. India.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.5.3. India: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.6. Orthobiologics Market - Malaysia
      • 8.5.6.1. Malaysia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.6.2. Malaysia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.6.3. Malaysia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.7. Orthobiologics Market - Japan
      • 8.5.7.1. Japan: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.7.2. Japan.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.7.3. Japan: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.8. Orthobiologics Market - Indonesia
      • 8.5.8.1. Indonesia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.8.2. Indonesia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.8.3. Indonesia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.5.9. Orthobiologics Market - South Korea
      • 8.5.9.1. South Korea: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.5.9.2. South Korea.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.5.9.3. South Korea: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.6. Orthobiologics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.6.2. Middle East & Africa.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.3. Middle East & Africa: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.4. Orthobiologics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.5. Orthobiologics Market - UAE
      • 8.6.5.1. UAE: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.5.2. UAE.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.5.3. UAE: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.6. Orthobiologics Market - Israel
      • 8.6.6.1. Israel: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.6.2. Israel.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.6.3. Israel: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.6.7. Orthobiologics Market - South Africa
      • 8.6.7.1. South Africa: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.6.7.2. South Africa.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.6.7.3. South Africa: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
  • 8.7. Orthobiologics Market - Latin America
    • 8.7.1. Latin America: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
    • 8.7.2. Latin America.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.7.3. Latin America: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.7.4. Orthobiologics Market - Mexico
      • 8.7.4.1. Mexico: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.7.4.2. Mexico.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.7.4.3. Mexico: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.7.5. Orthobiologics Market - Brazil
      • 8.7.5.1. Brazil: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.7.5.2. Brazil.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.7.5.3. Brazil: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)
    • 8.7.6. Orthobiologics Market - Argentina
      • 8.7.6.1. Argentina: Orthobiologics Market, by Product, 2018 - 2030 (USD Billion)
      • 8.7.6.2. Argentina.: Orthobiologics Market, by End-Use, 2018 - 2030 (USD Billion)
      • 8.7.6.3. Argentina: Orthobiologics Market, by Application, 2018 - 2030 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Alphatec Spine Incorporation
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Arthrex Inc.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bone Biologics Corporation
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bacterin International Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. DePuy Synthes, Incorporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Exactech, Inc
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Genzyme Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Globus Medical, Inc
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Globus Medical, Inc
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Harvest Technologies Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Integra Lifesciences Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Medtronic, Plc
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. NuVasive, Incorporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Orthofix Holdings, Inc
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Ortho Regenerative Technologies Inc
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Stryker Corporation
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
  • 10.17. SeaSpine Holdings Corporation
    • 10.17.1. Company Overview
    • 10.17.2. Financial Performance
    • 10.17.3. Product Benchmarking
    • 10.17.4. Recent Development
  • 10.18. Wright Medical Group N.V
    • 10.18.1. Company Overview
    • 10.18.2. Financial Performance
    • 10.18.3. Product Benchmarking
    • 10.18.4. Recent Development
  • 10.19. Zimmer Biomet, Inc
    • 10.19.1. Company Overview
    • 10.19.2. Financial Performance
    • 10.19.3. Product Benchmarking
    • 10.19.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제